Skip to main content
. 2019 May 27;79(9):957–968. doi: 10.1007/s40265-019-01125-w

Fig. 5.

Fig. 5

Serum phosphate levels in patients with chronic kidney disease treated with dialysis. The displayed 4-week, open-label, placebo-controlled period followed a 52-week, open-label, active-controlled period.

Based on data from the study reported in Lewis et al. [72]